Search research articles
Contact Us
Filters
Showing results (51-60 of 374) with videos related to
Page
of 38
Sort By:
Cancers
|
April 30, 2021
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data
Simona Duranti, Antonella Pietragalla, Gennaro Daniele, et al.
Therapeutics and Clinical Risk Management
|
October 20, 2010
Pegylated liposomal doxorubicin in the management of ovarian cancer
Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 13, 2015
Pneumoperitoneum pressures during pelvic laparoscopic surgery: a systematic review and meta-analysis
Giorgio Bogani, Fabio Martinelli, Antonino Ditto, et al.
Journal of Gynecologic Oncology
|
October 3, 2019
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, et al.
Tumori
|
March 29, 2019
Treatment of recurrent ovarian cancer with pegylated liposomal doxorubicin: a reappraisal and critical analysis
Domenica Lorusso, Ilaria Sabatucci, Giuseppa Maltese, et al.
Journal of Gynecologic Oncology
|
February 12, 2019
Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia
Giorgio Bogani, Antonino Ditto, Stefano Ferla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 13, 2022
Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, et al.
Current Problems in Cancer
|
February 26, 2023
Tisotumab vedotin in recurrent or metastatic cervical cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 27, 2011
Phase 2 trial of nonpegylated doxorubicin (Myocet) as second-line treatment in advanced or recurrent endometrial cancer
Alessia Di Legge, Ilaria Nausica Trivellizzi, Maria Cristina Moruzzi, et al.
Frontiers in Oncology
|
May 2, 2022
How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Gennaro Cormio, et al.
Page
of 38
Search research articles
Search
Showing results (51-60 of 374) with videos related to
Sort By:
Page
of 38
Cancers
|
April 30, 2021
Role of Immune Checkpoint Inhibitors in Cervical Cancer: From Preclinical to Clinical Data
Simona Duranti, Antonella Pietragalla, Gennaro Daniele, et al.
Therapeutics and Clinical Risk Management
|
October 20, 2010
Pegylated liposomal doxorubicin in the management of ovarian cancer
Gabriella Ferrandina, Giacomo Corrado, Angelo Licameli, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
October 13, 2015
Pneumoperitoneum pressures during pelvic laparoscopic surgery: a systematic review and meta-analysis
Giorgio Bogani, Fabio Martinelli, Antonino Ditto, et al.
Journal of Gynecologic Oncology
|
October 3, 2019
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, et al.
Tumori
|
March 29, 2019
Treatment of recurrent ovarian cancer with pegylated liposomal doxorubicin: a reappraisal and critical analysis
Domenica Lorusso, Ilaria Sabatucci, Giuseppa Maltese, et al.
Journal of Gynecologic Oncology
|
February 12, 2019
Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia
Giorgio Bogani, Antonino Ditto, Stefano Ferla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 13, 2022
Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, et al.
Current Problems in Cancer
|
February 26, 2023
Tisotumab vedotin in recurrent or metastatic cervical cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 27, 2011
Phase 2 trial of nonpegylated doxorubicin (Myocet) as second-line treatment in advanced or recurrent endometrial cancer
Alessia Di Legge, Ilaria Nausica Trivellizzi, Maria Cristina Moruzzi, et al.
Frontiers in Oncology
|
May 2, 2022
How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Gennaro Cormio, et al.
Page
of 38